Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders
In All, PortfolioHamburg, Germany, 22 March 2016 – Topas Therapeutics GmbH (“Topas”), a Hamburg/Germany based company, today announced the closing of its Series A financing round. This investment provides the company with EUR 14 million (USD 15.75 million). The round was led by Epidarex Capital and includes…